Form 4: Actinium Pharmaceuticals Director Cancels Stock Options
SEC Form 4 Filing
Jeffrey W. Chell, a director at Actinium Pharmaceuticals, canceled several stock options on March 31, 2025, as per an Option Cancellation and Release Agreement.
Summary
- On March 31, 2025, Jeffrey W. Chell, a director of Actinium Pharmaceuticals, canceled multiple stock options.
- The cancellation was executed under an Option Cancellation and Release Agreement between Chell and Actinium Pharmaceuticals.
- The canceled options had various exercise prices, ranging from $4.96 to $23.49.
- The expiration dates for these options ranged from April 27, 2028, to December 28, 2033.
- In total, Chell canceled options representing the right to buy 202,485 shares of Actinium Pharmaceuticals common stock.
- The cancellation was effective March 31, 2025, and was done in exchange for nominal consideration.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing regarding stock option cancellations. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and doesn't necessarily reflect broader industry trends.
Stakeholder Impact
- The cancellation of stock options by a director could have a minor impact on shareholder sentiment, but is unlikely to be material.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of the earliest transaction and effective date of stock option cancellation. |
| 04/02/2025 | Date of signature on the SEC Form 4. |
| 04/27/2028 | Expiration date of one set of canceled stock options. |
| 07/13/2028 | Expiration date of one set of canceled stock options. |
| 07/12/2029 | Expiration date of one set of canceled stock options. |
| 08/12/2030 | Expiration date of one set of canceled stock options. |
| 09/01/2031 | Expiration date of one set of canceled stock options. |
| 07/01/2032 | Expiration date of one set of canceled stock options. |
| 12/28/2033 | Expiration date of one set of canceled stock options. |
Keywords
Actinium Pharmaceuticals, Stock Options, Director, Cancellation, Jeffrey W. Chell, ATNM
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.